UM Guidelines

Medical Oncology GRG

General Recovery Guideline (GRG): PG-ONC

BCBST modification effective September 17, 2014*

Added to Clinical Indications for Allogeneic bone marrow or peripheral blood stem cell transplantation:
Myeloproliferative neoplasms


  1. A Cancer Journal for Clinicians. (2011, June). Advances in understanding and management of myeloproliferative neoplasms. Retrieved May 19, 2014 from
  2. BlueCross BlueShield Association. Medical Policy Reference Manual. (11:2013). Allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes and myeloproliferative neoplasms (8.01.21). Retrieved May 19, 2014 from BlueWeb.
  3. BlueCross BlueShield of Tennessee network physicians. June - September 2014.
  4. Complete Guide to Medicare Coverage Issues [Computer software]. (2014, May). Stem Cell Transplantation (NCD 110.8.1, p. 2-57). OptumInsight.